Mirimus' mission is to change the paradigm of the current drug discovery process by developing superior preclinical RNA interference (RNAi) animal models that can predict toxicities of potential drug therapies without the actual drug itself.

Biotechnology

Mirimus

Prem Premsrirut

Michelle Riley

Huaien Wang

James Connolly

Sean Seibel

Chia-Lin Wang

David Eads

Giuseppe Militello

Hui-Ting Cheng

Ana Vasileva

Veronica Andrews

The Advisory Team at Mirimus provides expert guidance and strategic insights to enhance the development and application of preclinical RNA interference (RNAi) animal models, ensuring they accurately predict drug toxicities and optimize the drug discovery process. This team leverages diverse expertise in scientific research and strategic planning to support and refine Mirimus' innovative mission.

Advisory Team

Leadership Team

Scientific Research

Advisory Team

About

Team members

Other teams at Mirimus

Leadership Team

Scientific Research